"Texas Oncology is an independent private practice with more than 500 physicians and 210 locations across the state. Meeting the oncology needs of Texans for more than 35 years, the practice includes Texas Center for Proton Therapy, Texas Breast Specialists, Texas Oncology Surgical Specialists, and Texas Center for Interventional Surgery. As a lead participant in US Oncology Research, Texas Oncology played a role in the development of more than 100 FDA-approved therapies."

During the past decade, Texas Oncology-Denton South conducted 40 clinical trials. In the 10-year time frame, 40 clinical trials started and 44 clinical trials were completed, i.e. on average, 110% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 22 clinical trials were completed. i.e. 115.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Texas Oncology-Denton South" #1 sponsor was "US Oncology Research" with 10 trials, followed by "Radiation Therapy Oncology Group" with 9 trials sponsored, "Bristol-Myers Squibb" with 4 trials sponsored, "Eli Lilly and Company" with 4 trials sponsored and "Gilead Sciences" with 4 trials sponsored. Other sponsors include 51 different institutions and companies that sponsored additional 41 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Texas Oncology-Denton South" #1 collaborator was "National Cancer Institute (NCI)" with 13 trials as a collaborator, "NRG Oncology" with 12 trials as a collaborator, "Bristol-Myers Squibb" with 5 trials as a collaborator, "Eli Lilly and Company" with 3 trials as a collaborator and "Sanofi" with 3 trials as a collaborator. Other collaborators include 19 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Texas Oncology-Denton South" are "Breast Cancer" (14 trials), "Metastatic Breast Cancer" (7 trials), "Lung Cancer" (5 trials), "Prostate Cancer" (5 trials) and "Non-Small Cell Lung Cancer" (4 trials). Many other conditions were trialed in "Texas Oncology-Denton South" in a lesser frequency.

Most popular intervention types in "Texas Oncology-Denton South" are "Drug" (72 trials), "Other" (13 trials), "Radiation" (13 trials), "Biological" (12 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Carboplatin" (7 trials), "Docetaxel" (7 trials), "Paclitaxel" (7 trials) and "Cyclophosphamide" (5 trials). Other intervention names were less common.

The vast majority of trials in "Texas Oncology-Denton South" are 62 trials for "All" genders, 15 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are NaN active trials in "Texas Oncology-Denton South". undefined are not yet recruiting, 11 are recruiting, 18 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 46 completed trials in Texas Oncology-Denton South, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Texas Oncology-Denton South, 3 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 51 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".